Urological Manifestations  >>  Tekturna (aliskiren)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tekturna (aliskiren) / PDL
NCT00097955: Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Completed
2
496
US, Canada, Europe, RoW
aliskiren
Novartis Pharmaceuticals
Diabetic Nephropathy
04/07
04/07
ARIA, NCT01302899 / 2009-012196-10: To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

Terminated
2
8
Europe
Aliskiren, Placebo to Aliskiren, Hydrochlorothiazide (HCTZ), Placebo to Hydrochlorothiazide (HCTZ), Ramipril
Novartis Pharmaceuticals
Non-diabetic Nephropathy
12/11
12/11

Download Options